Compare High Dividend Stocks

Compare High Dividend stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., WBA, BMY, BXP, CCI) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
WBA Walgreens Boots Alliance	$11.10 -0.2%	$10.96	$8.08 ▼ $22.05	$9.59B	0.62	20.81 million shs	37.25 million shs
BMY Bristol-Myers Squibb	$61.06 +1.1%	$58.17	$39.35 ▼ $63.33	$123.92B	0.43	12.18 million shs	25.86 million shs
BXP Boston Properties	$68.50 +0.0%	$70.28	$56.46 ▼ $90.11	$10.84B	1.19	1.18 million shs	2.90 million shs
CCI Crown Castle	$106.61 +1.9%	$92.77	$84.20 ▼ $120.92	$46.42B	0.89	2.64 million shs	9.21 million shs
DOC Healthpeak Properties	$20.02 -1.6%	$20.24	$17.45 ▼ $23.26	$14.00B	1.14	4.64 million shs	7.43 million shs
KMI Kinder Morgan	$27.90 -0.6%	$27.57	$17.61 ▼ $31.48	$61.98B	0.94	13.18 million shs	19.50 million shs
MO Altria Group	$57.46 -1.1%	$54.42	$40.65 ▼ $59.67	$97.14B	0.56	8.53 million shs	33.83 million shs
PFE Pfizer	$26.20 +0.1%	$26.17	$24.48 ▼ $31.54	$148.61B	0.61	36.65 million shs	349.78 million shs
T AT&T	$27.04 +0.9%	$25.13	$15.94 ▼ $27.97	$194.06B	0.56	34.32 million shs	91.27 million shs
VZ Verizon Communications	$44.06 +0.7%	$41.52	$37.59 ▼ $47.36	$185.46B	0.41	18.35 million shs	68.41 million shs

2025 Gold Forecast: A Perfect Storm for Demand

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
WBA Walgreens Boots Alliance	0.00%	-1.16%	+9.25%	+19.35%	-46.06%
BMY Bristol-Myers Squibb	0.00%	+3.48%	+9.35%	+6.05%	+17.59%
BXP Boston Properties	0.00%	+4.50%	-0.55%	-9.40%	+8.27%
CCI Crown Castle	0.00%	+3.31%	+15.62%	+17.48%	+3.71%
DOC Healthpeak Properties	0.00%	-2.10%	+1.37%	-0.82%	+14.11%
KMI Kinder Morgan	0.00%	+2.91%	+5.64%	+3.12%	+54.46%
MO Altria Group	0.00%	-2.57%	+4.46%	+7.24%	+33.68%
PFE Pfizer	0.00%	+1.82%	-0.43%	-1.89%	-4.23%
T AT&T	0.00%	+1.62%	+1.50%	+18.37%	+59.22%
VZ Verizon Communications	0.00%	+0.89%	+3.00%	+10.30%	+9.13%

Remove Ads

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
WBA Walgreens Boots Alliance	3.4466 of 5 stars	1.9	4.0	2.5	2.3	1.9	1.7	0.6
BMY Bristol-Myers Squibb	3.7669 of 5 stars	1.2	3.0	4.2	4.0	3.1	3.3	0.0
BXP Boston Properties	4.2293 of 5 stars	3.2	1.0	2.5	1.8	2.6	2.5	1.9
CCI Crown Castle	3.185 of 5 stars	2.3	3.0	1.7	2.9	2.2	1.7	0.0
DOC Healthpeak Properties	4.0137 of 5 stars	2.4	3.0	2.5	3.7	3.0	1.7	0.6
KMI Kinder Morgan	3.8093 of 5 stars	2.3	3.0	1.7	0.8	3.1	3.3	1.3
MO Altria Group	3.0977 of 5 stars	1.1	2.0	5.0	0.0	3.0	0.8	1.9
PFE Pfizer	4.9042 of 5 stars	2.3	3.0	4.2	4.2	2.8	3.3	3.1
T AT&T	4.3214 of 5 stars	2.4	3.0	3.3	3.7	2.8	0.8	1.9
VZ Verizon Communications	4.7659 of 5 stars	2.3	4.0	5.0	3.5	2.9	2.5	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
WBA Walgreens Boots Alliance	1.85	Reduce	$10.59	-4.59% Downside
BMY Bristol-Myers Squibb	2.32	Hold	$57.86	-5.25% Downside
BXP Boston Properties	2.46	Hold	$80.85	18.02% Upside
CCI Crown Castle	2.53	Moderate Buy	$110.00	3.18% Upside
DOC Healthpeak Properties	2.86	Moderate Buy	$23.92	19.53% Upside
KMI Kinder Morgan	2.60	Moderate Buy	$29.64	6.27% Upside
MO Altria Group	2.13	Hold	$53.29	-7.26% Downside
PFE Pfizer	2.63	Moderate Buy	$31.92	21.83% Upside
T AT&T	2.78	Moderate Buy	$26.79	-0.91% Downside
VZ Verizon Communications	2.56	Moderate Buy	$46.53	5.62% Upside

Current Analyst Ratings Breakdown

Latest High Dividend Stocks Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/20/2025	CCI Crown Castle	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral	$110.00
3/19/2025	T AT&T	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$27.00 ➝ $28.00
3/18/2025	PFE Pfizer	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
3/17/2025	BXP Boston Properties	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$78.00
3/17/2025	CCI Crown Castle	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$121.00 ➝ $115.00
3/17/2025	CCI Crown Castle	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$104.00 ➝ $113.00
3/17/2025	CCI Crown Castle	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Underweight ➝ Equal Weight	$85.00 ➝ $105.00
3/17/2025	CCI Crown Castle	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Underperform ➝ Peer Perform
3/14/2025	BXP Boston Properties	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$89.00 ➝ $79.00
3/14/2025	CCI Crown Castle	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$106.00 ➝ $108.00
3/14/2025	CCI Crown Castle	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Sector Perform ➝ Sector Perform	$102.00 ➝ $99.00

(Data available from 3/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
WBA Walgreens Boots Alliance	$150.41B	0.06	$6.07 per share	1.83	$13.91 per share	0.80
BMY Bristol-Myers Squibb	$48.30B	2.57	$6.44 per share	9.48	$8.08 per share	7.56
BXP Boston Properties	$3.41B	3.18	$7.52 per share	9.11	$50.21 per share	1.36
CCI Crown Castle	$6.57B	7.07	$8.85 per share	12.04	$14.71 per share	7.25
DOC Healthpeak Properties	$543.46M	25.76	$1.75 per share	11.43	$12.94 per share	1.55
KMI Kinder Morgan	$15.10B	4.10	$2.35 per share	11.87	$14.34 per share	1.95
MO Altria Group	$20.44B	4.75	$5.59 per share	10.28	($1.29) per share	-44.54
PFE Pfizer	$63.63B	2.34	$4.11 per share	6.38	$15.81 per share	1.66
T AT&T	$122.34B	1.59	$5.34 per share	5.06	$16.47 per share	1.64
VZ Verizon Communications	$134.79B	1.38	$9.18 per share	4.80	$23.89 per share	1.84

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
WBA Walgreens Boots Alliance	-$8.64B	-$10.24	N/A	7.60	1.31	-5.87%	17.61%	2.89%	3/27/2025 (Estimated)
BMY Bristol-Myers Squibb	-$8.95B	-$4.42	N/A	10.03	2.07	-18.53%	13.93%	2.46%	4/24/2025 (Estimated)
BXP Boston Properties	$14.27M	$0.10	685.07	9.42	0.91	0.38%	3.90%	1.24%	4/29/2025 (Estimated)
CCI Crown Castle	$1.50B	-$8.98	37.81	16.20	N/A	18.59%	20.98%	3.20%	4/16/2025 (Estimated)
DOC Healthpeak Properties	$243.14M	$0.35	57.19	10.26	2.17	9.00%	2.61%	1.21%	4/24/2025 (Estimated)
KMI Kinder Morgan	$2.61B	$1.17	23.84	21.62	3.08	17.31%	8.09%	3.62%	4/16/2025 (Estimated)
MO Altria Group	$11.26B	$6.55	8.77	10.37	2.89	46.90%	-258.72%	25.16%	4/24/2025 (Estimated)
PFE Pfizer	$8.03B	$1.41	18.58	8.65	0.64	12.62%	19.47%	8.09%	4/29/2025 (Estimated)
T AT&T	$10.95B	$1.49	18.14	11.91	3.00	8.95%	13.97%	4.16%	4/23/2025 (Estimated)
VZ Verizon Communications	$17.51B	$4.14	10.64	9.06	4.45	12.99%	19.80%	5.08%	4/28/2025 (Estimated)

Latest High Dividend Stocks Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
4/16/2025	N/A	CCI Crown Castle	$1.72	N/A	N/A	N/A	$1.04 billion	N/A
4/16/2025	N/A	KMI Kinder Morgan	$0.34	N/A	N/A	N/A	$4.02 billion	N/A
3/27/2025	N/A	WBA Walgreens Boots Alliance	$0.53	N/A	N/A	N/A	$37.90 billion	N/A
2/6/2025	Q4 2024	BMY Bristol-Myers Squibb	$1.47	$1.67	+$0.20	$0.04	$11.57 billion	N/A
2/4/2025	Q4 2024	PFE Pfizer	$0.48	$0.63	+$0.15	$0.07	$17.26 billion	$17.76 billion
1/30/2025	Q4 2024	MO Altria Group	$1.28	$1.29	+$0.01	$1.79	$5.04 billion	N/A
1/28/2025	Q4 2024	BXP Boston Properties	$0.51	$1.79	+$1.28	-$0.15	$843.55 million	N/A
1/27/2025	Q4 2024	T AT&T	$0.48	$0.54	+$0.06	$0.56	$31.94 billion	N/A
1/24/2025	Q4 2024	VZ Verizon Communications	$1.11	$1.10	-$0.01	$1.19	$35.49 billion	N/A
1/22/2025	Q4 2024	KMI Kinder Morgan	$0.33	$0.32	-$0.01	$0.30	$4.13 billion	N/A
1/10/2025	Q1 25	WBA Walgreens Boots Alliance	$0.38	$0.51	+$0.13	-$0.31	$37.40 billion	$39.50 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
WBA Walgreens Boots Alliance	$1.00	9.01%	-19.12%	N/A	N/A
BMY Bristol-Myers Squibb	$2.48	4.06%	+6.38%	N/A	17 Years
BXP Boston Properties	$3.92	5.72%	N/A	3,920.00%	N/A
CCI Crown Castle	$6.26	5.87%	+4.66%	N/A	N/A
DOC Healthpeak Properties	$1.22	6.10%	+34.01%	348.57%	N/A
KMI Kinder Morgan	$1.15	4.12%	-7.22%	98.29%	N/A
MO Altria Group	$4.08	7.10%	+4.35%	62.29%	56 Years
PFE Pfizer	$1.72	6.56%	+2.50%	121.99%	16 Years
T AT&T	$1.11	4.11%	-18.89%	74.50%	N/A
VZ Verizon Communications	$2.71	6.15%	+1.93%	65.46%	20 Years

Latest High Dividend Stocks Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
3/3/2025	BMY Bristol-Myers Squibb	quarterly	$0.62	4.14%	4/4/2025	4/4/2025	5/1/2025
2/28/2025	VZ Verizon Communications	quarterly	$0.6775	6.29%	4/10/2025	4/10/2025	5/1/2025
3/20/2025	BXP Boston Properties	quarterly	$0.98	5.69%	3/31/2025	3/31/2025	4/30/2025
2/27/2025	MO Altria Group	quarterly	$1.02	7.4%	3/25/2025	3/25/2025	4/30/2025
2/26/2025	CCI Crown Castle	quarterly	$1.5650	6.84%	3/14/2025	3/14/2025	3/31/2025
2/3/2025	DOC Healthpeak Properties	quarterly	$0.3050	5.98%	2/14/2025	2/14/2025	2/26/2025
1/22/2025	KMI Kinder Morgan	quarterly	$0.2875	3.74%	2/3/2025	2/3/2025	2/18/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
WBA Walgreens Boots Alliance	0.68	0.64	0.30
BMY Bristol-Myers Squibb	2.90	1.25	1.15
BXP Boston Properties	2.09	5.69	5.51
CCI Crown Castle	4.43	0.54	0.54
DOC Healthpeak Properties	0.96	1.35	1.35
KMI Kinder Morgan	0.94	0.49	0.39
MO Altria Group	N/A	0.51	0.39
PFE Pfizer	0.63	1.00	0.73
T AT&T	1.00	0.66	0.62
VZ Verizon Communications	1.21	0.63	0.59

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
WBA Walgreens Boots Alliance	58.59%
BMY Bristol-Myers Squibb	76.41%
BXP Boston Properties	98.72%
CCI Crown Castle	90.77%
DOC Healthpeak Properties	93.57%
KMI Kinder Morgan	62.52%
MO Altria Group	57.41%
PFE Pfizer	68.36%
T AT&T	57.10%
VZ Verizon Communications	62.06%

Insider Ownership

Company	Insider Ownership
WBA Walgreens Boots Alliance	17.50%
BMY Bristol-Myers Squibb	0.09%
BXP Boston Properties	1.35%
CCI Crown Castle	0.39%
DOC Healthpeak Properties	0.30%
KMI Kinder Morgan	12.64%
MO Altria Group	0.09%
PFE Pfizer	0.06%
T AT&T	0.07%
VZ Verizon Communications	0.02%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
WBA Walgreens Boots Alliance	325,000	864.15 million	712.93 million	Optionable
BMY Bristol-Myers Squibb	34,300	2.03 billion	2.03 billion	Optionable
BXP Boston Properties	780	158.21 million	155.98 million	Optionable
CCI Crown Castle	4,700	435.43 million	432.90 million	Optionable
DOC Healthpeak Properties	200	699.57 million	697.47 million	Optionable
KMI Kinder Morgan	10,500	2.22 billion	1.94 billion	Optionable
MO Altria Group	6,300	1.69 billion	1.69 billion	Optionable
PFE Pfizer	83,000	5.67 billion	5.66 billion	Optionable
T AT&T	160,700	7.18 billion	7.17 billion	Optionable
VZ Verizon Communications	117,100	4.21 billion	4.21 billion	Optionable

High Dividend Stocks Headlines

Recent News About These Companies

Is Verizon Communications Inc. (VZ) the Most Undervalued Dividend Stock to Buy According to Hedge Funds?

March 23 at 12:34 PM | insidermonkey.com

Verizon Communications Inc. (NYSE:VZ) Stake Increased by Vanguard Group Inc.

March 23 at 7:07 AM | marketbeat.com

Verizon Communications Inc. (NYSE:VZ) Shares Purchased by Stevens Capital Management LP

March 23 at 6:41 AM | marketbeat.com

Verizon Communications Inc. (NYSE:VZ) Shares Sold by M Holdings Securities Inc.

March 23 at 6:19 AM | marketbeat.com

Mizuho Markets Cayman LP Acquires Shares of 9,053 Verizon Communications Inc. (NYSE:VZ)

March 23 at 6:19 AM | marketbeat.com

Sei Investments Co. Buys 50,559 Shares of Verizon Communications Inc. (NYSE:VZ)

March 23 at 5:34 AM | marketbeat.com

iA Global Asset Management Inc. Has $311,000 Stock Position in Verizon Communications Inc. (NYSE:VZ)

March 23 at 4:42 AM | marketbeat.com

Bond Yields Are Falling: Grab These Wall Street High-Yield 6% Dividend Favorites Fast

March 22 at 7:48 AM | 247wallst.com

KLP Kapitalforvaltning AS Takes Position in Verizon Communications Inc. (NYSE:VZ)

March 22 at 7:12 AM | marketbeat.com

Intellus Advisors LLC Purchases New Holdings in Verizon Communications Inc. (NYSE:VZ)

March 22 at 6:43 AM | marketbeat.com

Verizon Communications Inc. (NYSE:VZ) Shares Sold by American Century Companies Inc.

March 22 at 6:33 AM | marketbeat.com

Verizon Communications Inc. (NYSE:VZ) Shares Bought by Mizuho Securities USA LLC

March 22 at 6:16 AM | marketbeat.com

Virtu Financial LLC Buys Shares of 203,096 Verizon Communications Inc. (NYSE:VZ)

March 22 at 6:08 AM | marketbeat.com

Sciencast Management LP Takes $2.74 Million Position in Verizon Communications Inc. (NYSE:VZ)

March 22 at 6:00 AM | marketbeat.com

Millstone Evans Group LLC Takes Position in Verizon Communications Inc. (NYSE:VZ)

March 22 at 5:49 AM | marketbeat.com

Verizon Enables Text Chatting Via Satellite Connections for the First Time

March 22 at 4:38 AM | propakistani.pk

Verizon Communications (NYSE:VZ) Trading 0.5% Higher - Here's What Happened

March 21 at 1:59 PM | marketbeat.com

ATT Vs. Verizon: The Difference

March 21 at 11:30 AM | seekingalpha.com

Wall Street Rotation to High-Yield Dividend Stocks Largest on Record: 4 Perfect Picks to Buy Now

March 21 at 7:11 AM | 247wallst.com

Wayfinding Financial LLC Buys Shares of 9,696 Verizon Communications Inc. (NYSE:VZ)

March 21 at 6:50 AM | marketbeat.com

Verizon Communications Inc. (NYSE:VZ) Shares Sold by Adams Diversified Equity Fund Inc.

March 21 at 6:41 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Price Targets on NVIDIA Rise in Front of Earnings
By Sarah Horvath | February 24, 2025
View Price Targets on NVIDIA Rise in Front of Earnings
5 S&P 500 Dividend Stocks Set to Reward Investors
By Sarah Horvath | February 24, 2025
View 5 S&P 500 Dividend Stocks Set to Reward Investors
Why Energy Transfer Belongs on Your Watchlist
By Jeffrey Neal Johnson | March 12, 2025
View Why Energy Transfer Belongs on Your Watchlist
Walgreens Boots Alliance: Don’t Write Off This Asset Champ Yet
By Jea Yu | March 11, 2025
View Walgreens Boots Alliance: Don’t Write Off This Asset Champ Yet
Win-Win Momentum Plays With Strong Dividend Yields
By Nathan Reiff | March 4, 2025
View Win-Win Momentum Plays With Strong Dividend Yields

High Dividend Stocks Company Descriptions

Walgreens Boots Alliance NASDAQ:WBA

$11.10 -0.02 (-0.18%)

Closing price 03/21/2025 04:00 PM Eastern

Extended Trading

$11.14 +0.04 (+0.32%)

As of 03/21/2025 07:58 PM Eastern

Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.

Bristol-Myers Squibb NYSE:BMY

$61.06 +0.64 (+1.07%)

Closing price 03/21/2025 03:59 PM Eastern

Extended Trading

$61.09 +0.02 (+0.04%)

As of 03/21/2025 08:00 PM Eastern

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Boston Properties NYSE:BXP

$68.50 +0.03 (+0.04%)

Closing price 03/21/2025 03:59 PM Eastern

Extended Trading

$68.36 -0.14 (-0.20%)

As of 03/21/2025 06:15 PM Eastern

Boston Properties, Inc. (NYSE: BXP) (BXP or the Company) is the largest publicly traded developer, owner, and manager of premier workplaces in the United States, concentrated in six dynamic gateway markets - Boston, Los Angeles, New York, San Francisco, Seattle, and Washington, DC. BXP has delivered places that power progress for our clients and communities for more than 50 years. BXP is a fully integrated real estate company, organized as a real estate investment trust (REIT). Including properties owned by joint ventures, BXP's portfolio totals 53.3 million square feet and 188 properties, including 10 properties under construction/redevelopment. BXP's properties include 167 office properties, 14 retail properties (including two retail properties under construction/redevelopment), six residential properties (including one residential property under construction) and one hotel. BXP is well-known for its inhouse building management expertise and responsiveness to clients' needs. BXP holds a superior track record of developing premium Central Business District (CBD) office buildings, successful mixed-use complexes, suburban office centers and build-to-suit projects for a diverse array of creditworthy clients. BXP actively works to promote its growth and operations in a sustainable and responsible manner. BXP has earned a twelfth consecutive GRESB Green Star recognition and the highest GRESB 5-star Rating. BXP, an S&P 500 company, was founded in 1970 by Mortimer B. Zuckerman and Edward H. Linde and became a public company in 1997.

Crown Castle NYSE:CCI

$106.61 +2.02 (+1.93%)

Closing price 03/21/2025 03:59 PM Eastern

Extended Trading

$105.72 -0.89 (-0.83%)

As of 03/21/2025 07:56 PM Eastern

Crown Castle owns, operates and leases more than 40,000 cell towers and approximately 90,000 route miles of fiber supporting small cells and fiber solutions across every major U.S. market. This nationwide portfolio of communications infrastructure connects cities and communities to essential data, technology and wireless service - bringing information, ideas and innovations to the people and businesses that need them.

Healthpeak Properties NYSE:DOC

$20.02 -0.34 (-1.65%)

Closing price 03/21/2025 03:58 PM Eastern

Extended Trading

$20.28 +0.27 (+1.32%)

As of 03/21/2025 07:34 PM Eastern

Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

Kinder Morgan NYSE:KMI

$27.90 -0.17 (-0.59%)

Closing price 03/21/2025 03:59 PM Eastern

Extended Trading

$27.85 -0.04 (-0.16%)

As of 03/21/2025 07:58 PM Eastern

Kinder Morgan, Inc. operates as an energy infrastructure company primarily in North America. The company operates through Natural Gas Pipelines, Products Pipelines, Terminals, and CO2 segments. The Natural Gas Pipelines segment owns and operates interstate and intrastate natural gas pipeline, and storage systems; natural gas gathering systems and natural gas processing and treating facilities; natural gas liquids fractionation facilities and transportation systems; and liquefied natural gas gasification, liquefaction, and storage facilities. The Products Pipelines segment owns and operates refined petroleum products, and crude oil and condensate pipelines; and associated product terminals and petroleum pipeline transmix facilities. The Terminals segment owns and/or operates liquids and bulk terminals that stores and handles various commodities, including gasoline, diesel fuel, renewable fuel and feedstocks, chemicals, ethanol, metals, and petroleum coke; and owns tankers. The CO2 segment produces, transports, and markets CO2 to recovery and production crude oil from mature oil fields; owns interests in/or operates oil fields and gasoline processing plants; and operates a crude oil pipeline system in West Texas, as well as owns and operates RNG and LNG facilities. It owns and operates approximately 82,000 miles of pipelines and 139 terminals. The company was formerly known as Kinder Morgan Holdco LLC and changed its name to Kinder Morgan, Inc. in February 2011. Kinder Morgan, Inc. was incorporated in 2006 and is headquartered in Houston, Texas.

Altria Group NYSE:MO

$57.46 -0.63 (-1.09%)

Closing price 03/21/2025 03:59 PM Eastern

Extended Trading

$57.58 +0.13 (+0.22%)

As of 03/21/2025 07:59 PM Eastern

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company offers cigarettes primarily under the Marlboro brand; large cigars and pipe tobacco under the Black & Mild brand; moist smokeless tobacco and snus products under the Copenhagen, Skoal, Red Seal, and Husky brands; oral nicotine pouches under the on! brand; and e-vapor products under the NJOY ACE brand. It sells its products to distributors, as well as large retail organizations, such as chain stores. The company was founded in 1822 and is headquartered in Richmond, Virginia.

Pfizer NYSE:PFE

$26.20 +0.01 (+0.05%)

Closing price 03/21/2025 03:59 PM Eastern

Extended Trading

$26.16 -0.04 (-0.17%)

As of 03/21/2025 08:00 PM Eastern

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

AT&T NYSE:T

$27.04 +0.25 (+0.91%)

Closing price 03/21/2025 03:59 PM Eastern

Extended Trading

$26.99 -0.05 (-0.17%)

As of 03/21/2025 07:59 PM Eastern

AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally. The Latin America segment provides wireless services and equipment in Mexico. The company was founded in 1983 and is headquartered in Dallas, TX.

Verizon Communications NYSE:VZ

$44.06 +0.31 (+0.70%)

Closing price 03/21/2025 03:59 PM Eastern

Extended Trading

$44.00 -0.05 (-0.12%)

As of 03/21/2025 07:59 PM Eastern

Verizon Communications Inc., through its subsidiaries, engages in the provision of communications, technology, information, and entertainment products and services to consumers, businesses, and governmental entities worldwide. It operates in two segments, Verizon Consumer Group (Consumer) and Verizon Business Group (Business). The Consumer segment provides wireless services across the wireless networks in the United States under the Verizon and TracFone brands and through wholesale and other arrangements; and fixed wireless access (FWA) broadband through its wireless networks, as well as related equipment and devices, such as smartphones, tablets, smart watches, and other wireless-enabled connected devices. The segment also offers wireline services in the Mid-Atlantic and Northeastern United States, as well as Washington D.C. through its fiber-optic network, Verizon Fios product portfolio, and a copper-based network. The Business segment provides wireless and wireline communications services and products, including FWA broadband, data, video and conferencing, corporate networking, security and managed network, local and long-distance voice, and network access services to deliver various IoT services and products to businesses, government customers, and wireless and wireline carriers in the United States and internationally. The company was formerly known as Bell Atlantic Corporation and changed its name to Verizon Communications Inc. in June 2000. Verizon Communications Inc. was incorporated in 1983 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare High Dividend Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare MarketRank™

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest High Dividend Stocks Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest High Dividend Stocks Earnings

Compare Dividends

Latest High Dividend Stocks Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

High Dividend Stocks Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

High Dividend Stocks Company Descriptions

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools